{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:22:25Z","timestamp":1777620145091,"version":"3.51.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T00:00:00Z","timestamp":1557878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oral Maxillofac Surg"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s10006-019-00778-x","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T17:02:31Z","timestamp":1557939751000},"page":"343-352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The expression of melanoma-associated antigen A (MAGE-A) in oral squamous cell carcinoma: an evaluation of the significance for tumor prognosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Anna","family":"Trippel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Halling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ayna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Al-Nawas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3296-7630","authenticated-orcid":false,"given":"Thomas","family":"Ziebart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,5,15]]},"reference":[{"issue":"3","key":"778_CR1","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.oraloncology.2008.05.008","volume":"45","author":"SN Rogers","year":"2009","unstructured":"Rogers SN, Brown JS, Woolgar JA, Lowe D, Magennis P, Shaw RJ, Sutton D, Erring-ton D, Vaughan D (2009) Survival following primary surgery for oral cancer. Oral Oncol 45(3):201\u2013211. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2008.05.008","journal-title":"Oral Oncol"},{"key":"778_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/hed.10354","volume":"26","author":"AL Carvalho","year":"2004","unstructured":"Carvalho AL, Singh B, Spiro RH, Kowalski LP, Shah JP (2004) Cancer of the oral cavity: a comparison between institutions in a developing and a developed nation. Head Neck 26:31\u201338","journal-title":"Head Neck"},{"key":"778_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.oraloncology.2008.06.002","volume":"45","author":"S Warnakulasuriya","year":"2009","unstructured":"Warnakulasuriya S (2009) Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 45:309\u2013316","journal-title":"Oral Oncol"},{"key":"778_CR4","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S0278-2391(03)00149-6","volume":"61","author":"WL Lo","year":"2003","unstructured":"Lo WL, Kao SY, Chi LY, Wong YK, Chang RC (2003) Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg 61:751\u2013758","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"778_CR5","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/15592294.2015.1006506","volume":"10","author":"YF Li","year":"2015","unstructured":"Li YF, Hsiao YH, Lai YH, Chen YC, Chen YJ, Chou JL, Chan MW, Lin YH, Tsou YA, Tsai MH, Tai CK (2015) DNA methylation profiles and biomarkers of oral squamous cell carcinoma. Epigenetics. 10(3):229\u2013236. \n                    https:\/\/doi.org\/10.1080\/15592294.2015.1006506","journal-title":"Epigenetics."},{"key":"778_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1056\/NEJMoa032641","volume":"350","author":"J Bernier","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lef\u00e8bvre JL, Greiner RH, Giralt J, Maingon P, Rolland F, Bolla M, Cognetti F, Bourhis J, Kirkpatrick A, van Glabbeke M (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350:1945\u20131952","journal-title":"N Engl J Med"},{"key":"778_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s00066-010-2245-8","volume":"187","author":"M Kreppel","year":"2011","unstructured":"Kreppel M, Drebber U, Eich HT, Dreiseidler T, Z\u00f6ller JE, M\u00fcller RP, Scheer M (2011) Combined-modality treatment in advanced oral squamous cell carcinoma with primary surgery followed by adjuvant radiochemotherapy. Strahlenther Onkol 187:555\u2013560","journal-title":"Strahlenther Onkol"},{"key":"778_CR8","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/cncr.23206","volume":"112","author":"A Lavaf","year":"2008","unstructured":"Lavaf A, Genden E, Cesaretti J et al (2008) Adjuvant radiotherapy improves overall survival for patients with lymph node-positive head and neck squamous cell carcinoma. Cancer 112:535\u2013543","journal-title":"Cancer"},{"key":"778_CR9","doi-asserted-by":"publisher","first-page":"450629","DOI":"10.1155\/2014\/450629","volume":"2014","author":"P Panta","year":"2014","unstructured":"Panta P, Venna VR (2014) Salivary RNA signatures in oral cancer detection. Analytical cellular pathology (Amsterdam) 2014:450629. \n                    https:\/\/doi.org\/10.1155\/2014\/450629","journal-title":"Analytical cellular pathology (Amsterdam)"},{"issue":"2","key":"778_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3892\/mco.2016.928","volume":"5","author":"T Naruse","year":"2016","unstructured":"Naruse T, Yanamoto S, Matsushita Y, Sakamoto Y, Morishita K, Ohba S, Shiraishi T, Yamada SI, Asahina I, Umeda M (2016) Cetuximab for the treatment of locally advanced and recurrent\/metastatic oral cancer: an investigation of distant metastasis. Mol Clin Oncol 5(2):246\u2013252. \n                    https:\/\/doi.org\/10.3892\/mco.2016.928","journal-title":"Mol Clin Oncol"},{"issue":"18","key":"778_CR11","doi-asserted-by":"publisher","first-page":"15772","DOI":"10.18632\/oncotarget.4694","volume":"6","author":"MF Gjerstorff","year":"2015","unstructured":"Gjerstorff MF, Andersen MH, Ditzel HJ (2015) Oncogenic cancer\/testis antigens: prime candidates for immunotherapy. Oncotarget 6(18):15772\u201315787","journal-title":"Oncotarget"},{"key":"778_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/1746-160X-5-10","volume":"5","author":"UD M\u00fcller-Richter","year":"2009","unstructured":"M\u00fcller-Richter UD, Dowejko A, Reuther T, Kleinheinz J, Reichert TE, Driemel O (2009) Analysis of expression profiles of MAGE-A antigens in oral squamous cell carcinoma cell lines. Head Face Med 5:10. \n                    https:\/\/doi.org\/10.1186\/1746-160X-5-10","journal-title":"Head Face Med"},{"key":"778_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/ITT.S35570","volume":"2","author":"DK Krishnadas","year":"2013","unstructured":"Krishnadas DK, Bai F, Lucas KG (2013) Cancer testis antigen and immunotherapy. ImmunoTargets and Therapy 2:11\u201319. \n                    https:\/\/doi.org\/10.2147\/ITT.S35570","journal-title":"ImmunoTargets and Therapy"},{"key":"778_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1471-2164-8-129","volume":"8","author":"BJ Stevenson","year":"2007","unstructured":"Stevenson BJ, Iseli C, Panji S, Zahn-Zabal M, Hide W, Old LJ, Simpson AJ, Jongeneel CV (2007) Rapid evolution of cancer\/testis genes on the X chromosome. BMC Genomics 8:129. \n                    https:\/\/doi.org\/10.1186\/1471-2164-8-129","journal-title":"BMC Genomics"},{"key":"778_CR15","doi-asserted-by":"crossref","unstructured":"Zhang Q and Su B. Evolutionary origin and human-specific expansion of a cancer\/testis antigen gene family. Mol Biol Evol 2014; 31:2365\u20132375","DOI":"10.1093\/molbev\/msu188"},{"key":"778_CR16","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.1840703","volume":"254","author":"P van der Bruggen","year":"1991","unstructured":"van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643\u20131647","journal-title":"Science."},{"issue":"14","key":"778_CR17","first-page":"5544","volume":"61","author":"P Chomez","year":"2001","unstructured":"Chomez P, De Backer O, Bertrand M, De Plaen E, Boon T, Lucas S (2001) An overview of the MAGE gene family with the identification of all human members of the family. Cancer Res 61(14):5544\u20135551","journal-title":"Cancer Res"},{"key":"778_CR18","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1158\/0008-5472.CAN-07-1478","volume":"67","author":"B Yang","year":"2007","unstructured":"Yang B, O\u2019Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov AV, Simpson AJ, Longley BJ (2007) MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 67:9954\u20139962","journal-title":"Cancer Res"},{"key":"778_CR19","doi-asserted-by":"publisher","first-page":"11160","DOI":"10.1073\/pnas.0510834103","volume":"103","author":"M Monte","year":"2006","unstructured":"Monte M, Simonatto M, Peche LY, Bublik DR, Gobessi S, Pierotti MA, Rodolfo M, Schneider C (2006) MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A 103:11160\u201311165","journal-title":"Proc Natl Acad Sci U S A"},{"key":"778_CR20","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molcel.2010.08.029","volume":"39","author":"JM Doyle","year":"2010","unstructured":"Doyle JM, Gao J, Wang J, Yang M, Potts PR (2010) MAGERING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 39:963\u2013974","journal-title":"Mol Cell"},{"key":"778_CR21","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/cdd.2011.173","volume":"19","author":"LY Peche","year":"2012","unstructured":"Peche LY, Scolz M, Ladelfa MF, Monte M, Schneider C (2012) MageA2 restrains cellular senescence by targeting the function of PMLIV\/p53 axis at the PML-NBs. Cell Death Differ 19:926\u2013936","journal-title":"Cell Death Differ"},{"key":"778_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.molonc.2014.09.001","volume":"9","author":"KB Greve","year":"2015","unstructured":"Greve KB, Lindgreen JN, Terp MG, Pedersen CB, Schmidt S, Mollenhauer J, Kristensen SB, Andersen RS, Relster MM, Ditzel HJ, Gjerstorff MF (2015) Ectopic expression of cancer\/testis antigen SSX2 induces DNA damage and promotes genomic instability. Mol Oncol 9:437\u2013449","journal-title":"Mol Oncol"},{"key":"778_CR23","doi-asserted-by":"publisher","first-page":"14475","DOI":"10.1074\/jbc.M109.084400","volume":"285","author":"E Por","year":"2010","unstructured":"Por E, Byun HJ, Lee EJ, Lim JH, Jung SY, Park I, Kim YM, Jeoung DI, Lee H (2010) The cancer\/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2Fdependent manner. J Biol Chem 285:14475\u201314485","journal-title":"J Biol Chem"},{"key":"778_CR24","doi-asserted-by":"publisher","first-page":"36502","DOI":"10.1074\/jbc.M113.502047","volume":"288","author":"Y Kim","year":"2013","unstructured":"Kim Y, Park D, Kim H, Choi M, Lee H, Lee YS, Choe J, Kim YM, Jeoung D (2013) miR-200b and cancer\/testis antigen CAGE form a feedback loop to regulate the invasion and tumorigenic and angiogenic responses of a cancer cell line to microtubule-targeting drugs. J Biol Chem 288:36502\u201336518","journal-title":"J Biol Chem"},{"key":"778_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1158\/1078-0432.CCR-05-1544","volume":"12","author":"C Barrow","year":"2006","unstructured":"Barrow C, Browning J, MacGregor D, Davis ID, Sturrock S, Jungbluth AA, Cebon J (2006) Tumor antigen expression in melanoma varies according to antigen and stage. Clin Cancer Res 12:764\u2013771","journal-title":"Clin Cancer Res"},{"key":"778_CR26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10549-014-2915-9","volume":"145","author":"F Yang","year":"2014","unstructured":"Yang F, Zhou X, Miao X, Zhang T, Hang X, Tie R, Liu N, Tian F, Wang F, Yuan J (2014) MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis. Breast Cancer Res Treat 145:23\u201332","journal-title":"Breast Cancer Res Treat"},{"key":"778_CR27","doi-asserted-by":"publisher","first-page":"e1285","DOI":"10.1038\/cddis.2014.244","volume":"5","author":"B Shang","year":"2014","unstructured":"Shang B, Gao A, Pan Y, Zhang G, Tu J, Zhou Y, Yang P, Cao Z, Wei Q, Ding Y, Zhang J, Zhao Y, Zhou Q (2014) CT45A1 acts as a new proto-oncogene to trigger tumorigenesis and cancer metastasis. Cell Death Dis 5:e1285","journal-title":"Cell Death Dis"},{"key":"778_CR28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.18632\/oncotarget.921","volume":"4","author":"OL Caballero","year":"2013","unstructured":"Caballero OL, Cohen T, Gurung S, Chua R, Lee P, Chen YT, Jat P, Simpson AJ (2013) Effects of CT-Xp gene knock down in melanoma cell lines. Oncotarget 4:531\u2013541","journal-title":"Oncotarget"},{"key":"778_CR29","doi-asserted-by":"crossref","unstructured":"De Craene B and Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13:97\u2013110","DOI":"10.1038\/nrc3447"},{"issue":"8","key":"778_CR30","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1002\/hed.21880","volume":"34","author":"JR Montoro","year":"2012","unstructured":"Montoro JR et al (2012) Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma. Head Neck 2012 34(8):1123\u20131128. \n                    https:\/\/doi.org\/10.1002\/hed.21880","journal-title":"Head Neck 2012"},{"key":"778_CR31","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3892\/ijo.2012.1532","volume":"41","author":"J Ries","year":"2012","unstructured":"Ries J, Agaimy A, Vairaktaris E, Kwon Y, Neukam FW, Strassburg LH, Nkenke E (2012) Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia. Int J Oncol 41:1085\u20131093. \n                    https:\/\/doi.org\/10.3892\/ijo.2012.1532","journal-title":"Int J Oncol"},{"issue":"1","key":"778_CR32","first-page":"541","volume":"8","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhai X, Wang G et al (2015) High expression of MAGE-A9 in tumor and stromal cells of non-small cell lung cancer was correlated with patient poor survival. Int J Clin Exp Pathol 8(1):541\u2013550","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"778_CR33","first-page":"6734","volume":"7","author":"L Han","year":"2014","unstructured":"Han L, Jiang B, Wu H, Zhang S, Lu X (2014) Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma. Int J Clin Exp Pathol 7(10):6734\u20136742","journal-title":"Int J Clin Exp Pathol"},{"issue":"2","key":"778_CR34","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.19082\/3756","volume":"9","author":"K Anvari","year":"2017","unstructured":"Anvari K, Pakdel AF, Memar B, Parsamanesh R, Ejlalzadeh SM, Javadinia SA (2017) The prevalence and expression pattern of melanoma-associated antigen 1 in esophageal squamous cell carcinoma: a historical cohort study. Electron Physician 9(2):3756\u20133763. \n                    https:\/\/doi.org\/10.19082\/3756","journal-title":"Electron Physician"},{"issue":"4","key":"778_CR35","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.3892\/ol.2016.4945","volume":"12","author":"S Hartmann","year":"2016","unstructured":"Hartmann S, Brisam M, Rauthe S, Driemel O, Brands RC, Rosenwald A, K\u00fcbler AC, M\u00fcller-Richter UDA (2016) Contrary melanoma-associated antigen-a expression at the tumor front and center: a comparative analysis of stage I and IV head and neck squamous cell carcinoma. Oncol Lett 12(4):2942\u20132947. \n                    https:\/\/doi.org\/10.3892\/ol.2016.4945","journal-title":"Oncol Lett"},{"issue":"9","key":"778_CR36","doi-asserted-by":"publisher","first-page":"14719","DOI":"10.18632\/oncotarget.14830","volume":"8","author":"S Laban","year":"2017","unstructured":"Laban S, Giebel G, Kl\u00fcmper N, Schr\u00f6ck A, Doescher J, Spagnoli G, Thierauf J, Theodoraki MN, Remark R, Gnjatic S, Krupar R, Sikora AG, Litjens G, Grabe N, Kristiansen G, Bootz F, Schuler PJ, Brunner C, Br\u00e4gelmann J, Hoffmann TK, Perner S (2017) MAGE expression in head and neck squamous cell carcinoma primary tumors, lymph node metastases and respective recurrences-implications for immunotherapy. Oncotarget 8(9):14719\u201314735. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14830","journal-title":"Oncotarget"},{"key":"778_CR37","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1158\/1078-0432.CCR-06-0527","volume":"12","author":"P Sharma","year":"2006","unstructured":"Sharma P, Shen Y, Wen S, Bajorin DF, Reuter VE, Old LJ, Jungbluth AA (2006) Cancer-testis antigens: expression and correlation with survival in human urothelial carcinoma. Clin Cancer Res 12:5442\u20135447","journal-title":"Clin Cancer Res"},{"issue":"2","key":"778_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1074\/mcp.M112.019786","volume":"12","author":"T Cabez\u00f3n","year":"2013","unstructured":"Cabez\u00f3n T, Gromova I, Gromov P, Serizawa R, Timmermans Wielenga V, Kroman N, Celis JE, Moreira JMA (2013) Proteomic profiling of triple-negative breast carcinomas in combination with a three-tier orthogonal technology approach identifies Mage-A4 as potential therapeutic target in estrogen receptor negative breast cancer. Mol Cell Proteomics 12(2):381\u2013394. \n                    https:\/\/doi.org\/10.1074\/mcp.M112.019786","journal-title":"Mol Cell Proteomics"},{"key":"778_CR39","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1002\/ijc.25607","volume":"128","author":"C Cuffel","year":"2011","unstructured":"Cuffel C, Rivals JP, Zaugg Y, Salvi S, Seelentag W, Speiser DE, Li\u00e9nard D, Monnier P, Romero P, Bron L, Rimoldi D (2011) Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma. Int J Cancer 128:2625\u20132634","journal-title":"Int J Cancer"},{"key":"778_CR40","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.4161\/cbt.5.9.3174","volume":"5","author":"D Atanackovic","year":"2006","unstructured":"Atanackovic D, Blum I, Cao Y, Wenzel S, Bartels K, Faltz C, Hossfeld DK, Hegewisch-Becker S, Bokemeyer C, Leuwer R (2006) Expression of cancer-testis antigens as possible targets for antigen-specific immunotherapy in head and neck squamous cell carcinoma. Cancer Biol Ther 5:1218\u20131225","journal-title":"Cancer Biol Ther"},{"key":"778_CR41","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/hed.10223","volume":"25","author":"MA Kienstra","year":"2003","unstructured":"Kienstra MA, Neel HB, Strome SE, Roche P (2003) Identification of NY-ESO-1, MAGE-1, and MAGE-3 in head and neck squamous cell carcinoma. Head Neck 25:457\u2013463","journal-title":"Head Neck"},{"key":"778_CR42","first-page":"22","volume":"22","author":"M Pastorcic-Grgic","year":"2009","unstructured":"Pastorcic-Grgic M, Sarcevic B, Dosen D, Juretic A, Spagnoli GC, Grgic M (2009) Prognostic value of MAGE-A and NYESO-1 expression in pharyngeal cancer. Head Neck 22:22","journal-title":"Head Neck"},{"key":"778_CR43","first-page":"5037","volume":"19","author":"KD Lee","year":"1999","unstructured":"Lee KD, Chang HK, Jo YK, Kim BS, Lee BH, Lee YW, Lee HK, Huh MH, Min YG, Spagnoli GC, Yu TH (1999) Expression of the MAGE 3 gene product in squamous cell carcinomas of the head and neck. Anticancer Res 19:5037\u20135042","journal-title":"Anticancer Res"},{"key":"778_CR44","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.3892\/ol.2017.5665","volume":"13","author":"X Chen","year":"2017","unstructured":"Chen X, Wang L, Liu J, Huang L, Yang L, Gao Q, Zhang Y (2017) Expression and prognostic relevance of MAGE-A3 and MAGE-C2 in non-small cell lung cancer. Oncol Lett 13:1609\u20131628","journal-title":"Oncol Lett"},{"key":"778_CR45","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/ijc.10540","volume":"100","author":"T Kocher","year":"2002","unstructured":"Kocher T, Zheng M, Bolli M, Simon R, Forster T, Schultz-Thater E, Remmel E, Noppen C, Schmid U, Ackermann D, Mihatsch MJ, Gasser T, Heberer M, Sauter G, Spagnoli GC (2002) Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray study. Int J Cancer 100:702\u2013705. \n                    https:\/\/doi.org\/10.1002\/ijc.10540","journal-title":"Int J Cancer"},{"issue":"10","key":"778_CR46","first-page":"1541","volume":"117","author":"CQ Jiang","year":"2004","unstructured":"Jiang CQ, Fan LF, Liu ZS, Qian Q, Xia D, Diao LM, He YM, Ai ZL (2004 Oct) Expression levels and significance of hypoxia inducible factor-1 alpha and vascular endothelial growth factor in human colorectal adenocarcinoma. Chin Med J 117(10):1541\u20131546","journal-title":"Chin Med J"},{"issue":"1","key":"778_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1054\/bjoc.2000.1537","volume":"84","author":"CD Dalley","year":"2001","unstructured":"Dalley CD, Lister TA, Cavenagh JD, Rohatiner AZS (2001) Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia. Br J Cancer 84(1):147. \n                    https:\/\/doi.org\/10.1054\/bjoc.2000.1537","journal-title":"Br J Cancer"},{"issue":"12","key":"778_CR48","first-page":"5125","volume":"29","author":"J Ries","year":"2009","unstructured":"Ries J, Mollaoglu N, Vairaktaris E, Neukam FW, Nkenke E (2009) Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma. Anticancer Res 29(12):5125\u20135130","journal-title":"Anticancer Res"},{"key":"778_CR49","first-page":"2778","volume":"9","author":"Z Duan","year":"2003","unstructured":"Duan Z, Duan Y, Lamendola DE, Yusuf RZ, Naeem R, Penson RT, Seiden MV (2003) Over-expression of MAGE\/GAGE genes in paclitaxel\/doxorubicin-resistant human cancer cell lines. Clin Cancer Res 9:2778\u20132785","journal-title":"Clin Cancer Res"},{"issue":"1","key":"778_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00784-013-0936-0","volume":"18","author":"S Hartmann","year":"2014","unstructured":"Hartmann S, Kriegebaum U, K\u00fcchler N, Brands RC, Linz C, K\u00fcbler AC, M\u00fcller-Richter UD (2014) Correlation of MAGE-A tumor antigens and the efficacy of various chemotherapeutic agents in head and neck carcinoma cells. Clin Oral Investig 18(1):189\u2013197. \n                    https:\/\/doi.org\/10.1007\/s00784-013-0936-0","journal-title":"Clin Oral Investig"},{"key":"778_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.jcms.2012.12.006","volume":"41","author":"S Hartmann","year":"2013","unstructured":"Hartmann S, Kriegebaum U, K\u00fcchler N, Lessner G, Brands RC, Linz C, Schneider T, K\u00fcbler AC, M\u00fcller-Richter UD (2013) Efficacy of cetuximab and panitumumab in oral squamous cell carcinoma cell lines: prognostic value of MAGE-A subgroups for treatment success. J Craniomaxillofac Surg 41:623\u2013629","journal-title":"J Craniomaxillofac Surg"},{"issue":"5","key":"778_CR52","doi-asserted-by":"publisher","first-page":"e3755","DOI":"10.17795\/ijcp-3755","volume":"8","author":"S Ghafouri-Fard","year":"2015","unstructured":"Ghafouri-Fard S, Seifi-Alan M, Shamsi R, Esfandiary A (2015) Immunotherapy in multiple myeloma using cancer-testis antigens. Iran J Cancer Prevention 8(5):e3755. \n                    https:\/\/doi.org\/10.17795\/ijcp-3755","journal-title":"Iran J Cancer Prevention"},{"issue":"7","key":"778_CR53","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1200\/JCO.2010.32.2537","volume":"29","author":"PF Robbins","year":"2011","unstructured":"Robbins PF, Morgan RA, Feldman SA, Yang JC, Sherry RM, Dudley ME, Wunderlich JR, Nahvi AV, Helman LJ, Mackall CL, Kammula US, Hughes MS, Restifo NP, Raffeld M, Lee CCR, Levy CL, Li YF, el-Gamil M, Schwarz SL, Laurencot C, Rosenberg SA (2011) Tumor regression in patients with metastatic synovial cell sarcoma and melanoma using genetically engineered lymphocytes reactive with NY-ESO-1. J Clin Oncol 29(7):917\u2013924. \n                    https:\/\/doi.org\/10.1200\/JCO.2010.32.2537","journal-title":"J Clin Oncol"},{"issue":"8","key":"778_CR54","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/CJI.0b013e318158fcff","volume":"30","author":"S Szmania","year":"2007","unstructured":"Szmania S, Gnjatic S, Tricot G, Stone K, Zhan F, Moreno A, Thuro B, Melenhorst J, Barrett J, Shaughnessy J, Old LJ, Barlogie B, Brichard VG, van Rhee F (2007) Immunization with a recombinant MAGE-A3 protein after high-dose therapy for myeloma. J Immunother 30(8):847\u2013854","journal-title":"J Immunother"}],"container-title":["Oral and Maxillofacial Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-019-00778-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10006-019-00778-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10006-019-00778-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T23:26:38Z","timestamp":1589412398000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10006-019-00778-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,15]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["778"],"URL":"https:\/\/doi.org\/10.1007\/s10006-019-00778-x","relation":{},"ISSN":["1865-1550","1865-1569"],"issn-type":[{"value":"1865-1550","type":"print"},{"value":"1865-1569","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,15]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The local ethics committee (Landes\u00e4rztekammer Rheinland-Pfalz) approved the following experiments (Ethikvotum 837.837.11 (7924)). This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}